Lasa Supergenerics zooms 8 per cent; heres why!

Currently, all units of the company are up and running.

Lasa Supergenerics announced that it has resumed manufacturing operations in plants located at Mahad. Besides, the company has also restarted operations in units situated in Chiplun (both in Maharashtra) within a week of floods. Currently, all units of the company are up and running. 

Commenting on the recent development, Dr Omkar Herlekar, Chairman & Managing Director said, “It is heartening to comment on restart of activities. We are fortunate enough to come back soon with the efforts of our dedicated team and also targetting to meet the time gap of production in a quarter. We are confident enough to surpass all our previous records with respect to production and cautiously optimistic as well as staying agile to cater to evolving demand. We are committed to growing and I assure you that we will not leave any stone unturned to achieve our goals.” 

Lasa Supergenerics is a globally well-trusted brand with high-quality products, accepted by large companies globally. It stands as pioneer amongst the leading players in the manufacturing of veterinary APIs. Its state-of-art manufacturing facilities are situated in Mahad and Chiplun with a total installed capacity of 4,300 MT. It exports 25 per cent of APIs to counties like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan, etc.